ロード中...

Investigating the Vascular Toxicity Outcomes of the Irreversible Proteasome Inhibitor Carfilzomib

Background: Carfilzomib’s (Cfz) adverse events in myeloma patients include cardiovascular toxicity. Since carfilzomib’s vascular effects are elusive, we investigated the vascular outcomes of carfilzomib and metformin (Met) coadministration. Methods: Mice received: (i) saline; (ii) Cfz; (iii) Met; (i...

詳細記述

保存先:
書誌詳細
主要な著者: Panagiotis Efentakis, Hendrik Doerschmann, Claudius Witzler, Svenja Siemer, Panagiota-Efstathia Nikolaou, Efstathios Kastritis, Roland Stauber, Meletios Athanasios Dimopoulos, Philip Wenzel, Ioanna Andreadou, Evangelos Terpos
フォーマット: Artigo
言語:Inglês
出版事項: MDPI AG 2020-07-01
シリーズ:International Journal of Molecular Sciences
主題:
オンライン・アクセス:https://www.mdpi.com/1422-0067/21/15/5185
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!